secwatch.observer — SEC 8-K summary
======================================

Issuer:     HTG MOLECULAR DIAGNOSTICS, INC (—)
CIK:        0001169987
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0000950170-23-027044
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

HTG Molecular Diagnostics receives Nasdaq delisting notice due to Chapter 11 filing; trading suspended June 15
--------------------------------------------------------------------------------

- Delisting notice received June 6, 2023 from Nasdaq staff after company's Chapter 11 bankruptcy filing.
- Trading of HTGM common stock suspended at open on June 15, 2023; Form 25-NSE to follow.
- Nasdaq cited concerns over continued listing compliance, residual equity interest, and public interest.
- Company does not intend to appeal the delisting determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1169987/000095017023027044/0000950170-23-027044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1169987/000095017023027044/htgm-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer